Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 574 (ZNF574) is a human protein encoded by the ZNF574 gene and belongs to the zinc finger protein family, specifically the C2H2-type, which are generally involved in binding DNA and regulating gene transcription[1][2][7]. ZNF574 is predicted to function as a DNA-binding transcription activator, acting in a sequence-specific manner at RNA polymerase II cis-regulatory regions, and is thought to exert its function within the nucleus[1][2][7]. While ZNF574 is not a classical therapeutic target such as a receptor, enzyme, or ion channel, it has gained interest in cancer research: it has been characterized as an oncogene, implicated in regulating cell proliferation and migration through pathways such as AKT and AMPK, particularly in ovarian and colorectal cancers[1]. There are currently no approved drugs known to specifically target ZNF574, nor is it established as a biomarker or subject to notable safety concerns in therapeutic contexts[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 574 (ZNF574).